Kawano K - Search Results

1

The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.

Takekuma M, Mori K, Iida T, Kurihara K, Saitou M, Tokunaga H, Kawana K, Ikeda M, Satoh T, Saito T, Miyagi E, Nagai Y, Furusawa A, Kawano Y, Kawano K, Tabata T, Ota Y, Hayase R, Mikami M, Sugiyama T. Takekuma M, et al. Among authors: kawano k, kawano y. Cancer Chemother Pharmacol. 2017 Oct;80(4):697-705. doi: 10.1007/s00280-017-3402-x. Epub 2017 Aug 7. Cancer Chemother Pharmacol. 2017. PMID: 28785994

2

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.

Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K, Yamaguchi T, Nishida N, Kakuma T, Tsuda H, Kasamatsu T, Sasajima Y, Kage M, Kuwano M, Kamura T. Nishio S, et al. Among authors: kawano k. Cancer Lett. 2008 Jun 8;264(1):36-43. doi: 10.1016/j.canlet.2008.01.020. Epub 2008 Feb 20. Cancer Lett. 2008. PMID: 18281151

3

Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients.

Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T. Kawano K, et al. Immunopharmacol Immunotoxicol. 2014 Jun;36(3):224-36. doi: 10.3109/08923973.2014.913617. Epub 2014 Apr 29. Immunopharmacol Immunotoxicol. 2014. PMID: 24773550 Clinical Trial.

4

Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods.

Matsumoto K, Yaegashi N, Iwata T, Ariyoshi K, Fujiwara K, Shiroyama Y, Usami T, Kawano Y, Horie K, Kawano K, Noda K, Yoshikawa H; MINT Study Group. Matsumoto K, et al. Among authors: kawano k, kawano y. Jpn J Clin Oncol. 2014 Oct;44(10):1000-3. doi: 10.1093/jjco/hyu097. Epub 2014 Aug 6. Jpn J Clin Oncol. 2014. PMID: 25098705

5

Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy.

Kawano K, Tsuda N, Waki K, Matsueda S, Hata Y, Ushijima K, Itoh K, Yamada A, Kamura T. Kawano K, et al. Cancer Sci. 2015 Sep;106(9):1111-7. doi: 10.1111/cas.12729. Epub 2015 Jul 22. Cancer Sci. 2015. PMID: 26122553 Free PMC article. Clinical Trial.

6

Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.

Waki K, Kawano K, Tsuda N, Ushijima K, Itoh K, Yamada A. Waki K, et al. Among authors: kawano k. J Immunol Res. 2017;2017:1423683. doi: 10.1155/2017/1423683. Epub 2017 Apr 27. J Immunol Res. 2017. PMID: 28536706 Free PMC article. Clinical Trial.

7

Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402).

Hirakawa T, Minaguchi T, Itani Y, Kasamatsu Y, Murase S, Sakurada S, Nagano H, Takehara K, Tsuruta T, Arakawa A, Kawano K, Tsubamoto H, Ushiwaka T, Mori T, Iwai K, Saito M, Morisawa H, Saito F, Yoshida K, Kaneuchi M, Sato H, Ito K, Nasu K. Hirakawa T, et al. Among authors: kawano k. World J Surg Oncol. 2017 Jul 17;15(1):132. doi: 10.1186/s12957-017-1200-x. World J Surg Oncol. 2017. PMID: 28716033 Free PMC article.

8

A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis.

Nishio S, Shimokawa M, Tasaki K, Nasu H, Yoshimitsu T, Matsukuma K, Terada A, Tsuda N, Kawano K, Ushijima K. Nishio S, et al. Among authors: kawano k. Gynecol Oncol. 2018 Sep;150(3):432-437. doi: 10.1016/j.ygyno.2018.07.014. Epub 2018 Jul 21. Gynecol Oncol. 2018. PMID: 30037491 Clinical Trial.

9

CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine-treated ovarian cancer patients.

Waki K, Kawano K, Tsuda N, Komatsu N, Yamada A. Waki K, et al. Among authors: kawano k. Cancer Sci. 2020 Apr;111(4):1124-1131. doi: 10.1111/cas.14349. Epub 2020 Mar 6. Cancer Sci. 2020. PMID: 32058620 Free PMC article.

10

Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study.

Ushijima K, Fujiyoshi K, Kawano K, Tsuda N, Nishio S, Eto H, Kamura T. Ushijima K, et al. Among authors: kawano k. J Gynecol Oncol. 2013 Apr;24(2):108-13. doi: 10.3802/jgo.2013.24.2.108. Epub 2013 Apr 5. J Gynecol Oncol. 2013. PMID: 23653826 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,348 results

Search Page

Filters